Doi Masahiro | Division Of Cardiology Department Of Medicine And Clinical Science Yamaguchi University Graduate Sch

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-068 Abnormally Tight Domain-Domain Interaction at Mutation Site could be a Primary Cause of Catecholaminergic Polymorphic Ventricular Tachycardia(PJ012,Calcium Handling, Cardiac Function (Basic) (M),Poster Session (Japanese),The 73rd Annual Scientific
PJ-564 Reduction of In-stent Restenosis by Undersized Stenting : A Study with Quantitative Coronary Analysis(Restenosis after Angioplasty, Basic/Clinical 6 (IHD) : PJ94)(Poster Session (Japanese))
Effects of Flecainide on the Electrophysiological Properties of Atrial Vulnerability in Humans
Factors Related to Threshold of Intra -Cardiac Atrial- Defibrillation : Excitable Period Obtained by Using Autocorrelogram
Determination of the refractory period during atrial fibrillation using autocorrelation function, and the observation of excitable gap during pharmacological cardioversion
Differed Ca^ Regulatory Effect of Candesartan or a New Cardioprotective Agent JTV519 on Improvement of Isoproterenol-Induced Dysfunction in Rats
Valsartan Restores Normal FKBP12.6-RyR Interaction by a Strong Inhibition of PKA-Mediated Hyperphosphorylation of RyR in Heart Failure
A novel cardioprotective agent, JTV519 improves cardiac function by restoring Ca^ -release function of cardiac sarcoplasmic reticulum in heart failure
Propranolol prevents the development of heart failure by FKBP12.6-mediated stabilization of ryanodine receptor in sarcoplasmic reticulum
FKBP12.6-mediated stabilization of calcium release channel (ryanodine receptor) as a novel therapeutic target in heart failure
What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
Urinary 8-Hydroxy-2'-Deoxyguanosine as a Novel Biomarker for Predicting Cardiac Events and Evaluating the Effectiveness of Carvedilol Treatment in Patients With Chronic Systolic Heart Failure
Characteristics of Induced Ventricular Fibrillation Cycle Length in Symptomatic Brugada Syndrome Patients
Low-Dose β-Blocker in Combination With Milrinone Safely Improves Cardiac Function and Eliminates Pulsus Alternans in Patients With Acute Decompensated Heart Failure
The Safety of Amiodarone for Heart Failure Patients with Atrial Fibrillation
Effects of isoproterenol and propranolo on the inducibility and frequency of ventricular fibrillation i npatients with Brugada syndrome
Effects of isoproterenol infusion on the ST segment and r of the QRS complex in the right precordial leads of the Brugada-type electrocardiogram pattern

もっと見る

スポンサーリンク